These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 574733)

  • 41. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.
    Donati F; Lahoud J; McCready D; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):589-93. PubMed ID: 3677283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of neostigmine, edrophonium, 4-aminopyridine and their combinations.
    Treffers R; Frankhuyzen AL; Booij LH
    Acta Anaesthesiol Belg; 1988; 39(1):55-8. PubMed ID: 2835880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanical responses to peroneal nerve stimulation in halothane-anesthetized horses in the absence of neuromuscular blockade and during partial nondepolarizing blockade.
    Klein C; Hopkins J; Beck E; Burton B
    Am J Vet Res; 1983 May; 44(5):781-5. PubMed ID: 6869983
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of acid-base balance on neostigmine antagonism of d-tubocurarine-induced neuromuscular blockade.
    Miller RD; Van Nyhuis LS; Eger EI; Way WL
    Anesthesiology; 1975 Apr; 42(4):377-83. PubMed ID: 235227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
    Miller RD; Roderick L
    Br J Pharmacol; 1977 Aug; 60(4):555-8. PubMed ID: 907868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine.
    Wali FA
    J Pharmacol; 1986; 17(3):244-53. PubMed ID: 3795969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bradycardia during antagonism of pancuronium-induced neuromuscular block.
    Heinonen J; Takkunen O
    Br J Anaesth; 1977 Nov; 49(11):1109-15. PubMed ID: 588391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Galanthamine versus neostigmine for reversal of nondepolarizing neuromuscular block in man.
    Baraka A; Cozanitis D
    Anesth Analg; 1973; 52(5):832-6. PubMed ID: 4738207
    [No Abstract]   [Full Text] [Related]  

  • 56. Antagonism of non-depolarising neuromuscular blockade by aminopyridines in cats.
    Riesz M; Kápáti E; Szporny L
    J Pharm Pharmacol; 1986 Feb; 38(2):156-8. PubMed ID: 2870165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
    Camu F; Sanders M; D'Hollander A
    Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of combination nondepolarized neuromuscular block.
    Vitez TS; Difrancesco LV
    Anesth Analg; 1983 Dec; 62(12):1081-2. PubMed ID: 6228170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig.
    Muir AW; Houston J; Marshall RJ; Bowman WC; Marshall IG
    Anesthesiology; 1989 Mar; 70(3):533-40. PubMed ID: 2564263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of ropivacaine combined with pancuronium on neuromuscular transmission and effectiveness of neostigmine and 4-aminopyridine for blockade reversal: experimental study].
    Braga Ade F; Carvalho VH; Braga FS; Potério GM; Santos FN
    Rev Bras Anestesiol; 2015; 65(2):136-40. PubMed ID: 25666937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.